"Design, Molecular Docking, and Pharmacokinetic Evaluation of Thioimidazole-4-one Derivatives for Asthma Treatment"
DOI:
https://doi.org/10.32947/ajps.v25i4.1290Keywords:
Thioimidazole-4-one derivatives, A2A adenosine receptor, ADME analysis, Molecular docking, Asthma therapyAbstract
This study investigates the design, molecular docking, and ADME properties of thioimidazole-4-one derivatives as potential therapeutic agents targeting the A2A adenosine receptor for asthma treatment. Computational molecular docking was performed using the A2A receptor complexed with theophylline (PDB ID: 5MZJ), and the compounds were compared to theophylline to evaluate binding affinity. Docking results revealed that the synthesized compounds showed stronger binding affinities than theophylline, with several compounds (e.g., 5y and 3y) exhibiting superior PLP fitness scores. These compounds formed hydrogen bonds and hydrophobic interactions with key residues of the A2A receptor, such as ASN253, TYR271, and GLU169, suggesting their potential to modulate asthma-related mechanisms like airway constriction and inflammation. ADME analysis, conducted using the SwissADME server, indicated that compounds Y1–Y6 possessed favorable pharmacokinetic properties, including good gastrointestinal absorption, moderate bioavailability, and no P-glycoprotein interactions, making them suitable for oral administration. However, compounds Y7 and Y8 exhibited lower gastrointestinal absorption and increased polarity, suggesting the need for further structural optimization. The findings suggest that these thioimidazole-4-one derivatives are promising candidates for asthma therapy, with potential for further development based on their molecular docking results and ADME profiles.
References
1- Sinyor B, Perez LC. Pathophysiology of asthma. StatPearls [Internet]: StatPearls Publishing; 2023.
2- Hirons B, Rhatigan K, Kesavan H, Turner RD, Birring SS, Cho PS. Cough in chronic lung disease: a state of the art review. Journal of Thoracic Disease. 2023;15(10):5823.
3- Yao Y, Borkar NA, Zheng M, Wang S, Pabelick CM, Vogel ER, et al. Interactions between calcium regulatory pathways and mechanosensitive channels in airways. Expert Review of Respiratory Medicine. 2023;17(10):903-17.
4- Adams C. Hay Fever and Allergies: Discovering the Real Culprits and Natural Solutions for Reversing Allergic Rhinitis: Logical Books; 2024.
5- Dodge RR, Burrows B. The prevalence and incidence of asthma and asthma-like symptoms in a general population sample. American review of respiratory disease. 1980;122(4):567-75.
6- Ora J, De Marco P, Gabriele M, Cazzola M, Rogliani P. Exercise-Induced Asthma: Managing Respiratory Issues in Athletes. Journal of Functional Morphology and Kinesiology. 2024;9(1):15.
7- Whittaker Brown S-A, Braman SS. Pulmonary Disease. Geriatric Medicine: A Person Centered Evidence Based Approach: Springer; 2023. p. 1-26.
8- Karunarathna I, De Alvis K, Gunasena P, Jayawardana A. Perioperative and intensive care management of chronic obstructive pulmonary disease (COPD) patients: A comprehensive review. Retrieved from ResearchGate; 2024.
9- Maryoosh AA, Al-Jeilawi OH. Synthesis, Characterization of Different Five-Membered Heterocyclic Derivatives, Evaluated Their as Antioxidant, and In Vitro Antimicrobial Agents. Russian Journal of Bioorganic Chemistry. 2024;50(4):1551-62.
10- Mahmood SA, Rauf AM, Aburjai T. In silico Study of New Five-Membered Heterocyclic Derivatives Bearing (1, 3, 4-oxadiazole and 1, 3, 4-thiadiazole) As Promising Cyclooxygenase Inhibitors. Al Mustansiriyah Journal of Pharmaceutical Sciences. 2024;24(3):237-51.
11- Xu L, Rong Y, Liao H, Pan M, Qian Y, Rong L, et al. Construction of Spiro [benzo [a] acridine-12, 4′-imidazolidine]-2′, 5′-dione Derivatives via Ring-Opening and Recyclization of Isatins and C–OH Cleavage of 2-Naphthol. The Journal of Organic Chemistry. 2023;88(11):6995-7005.
12- Shehab AK, Rasheed MK. Synthesis, characterization and antibacterial activity of thiazolidine-4-one and imidazolidine-4-one derived from Mesalazine drug by microwave method. International Journal of Health Sciences. 2022(I):12446-56.
13- Ismaeel SS, Mahdi MF, Abd Razik BM. Design, synthesis and antibacterial study of new agents having 4-thiazolidinone pharmacophore. Egyptian Journal of Chemistry. 2020;63(7):2591-603.
14- Irfan FRM, Masters SL. Structural and thermochemical investigation of 1, 3-bis (λ 4-boraneyl)-1λ 4, 3λ 4-imidazolidine adduct for chemical hydrogen storage. Physical Chemistry Chemical Physics. 2024;26(21):15765-75.
15- Pasquini S, Contri C, Borea PA, Vincenzi F, Varani K. Adenosine and inflammation: here, there and everywhere. International journal of molecular sciences. 2021;22(14):7685.
16- Pacini ESA, Satori NA, Jackson EK, Godinho RO. Extracellular cAMP-adenosine pathway signaling: a potential therapeutic target in chronic inflammatory airway diseases. Frontiers in Immunology. 2022;13:866097.
17- Vidal-Limon A, Aguilar-Toalá JE, Liceaga AM. Integration of molecular docking analysis and molecular dynamics simulations for studying food proteins and bioactive peptides. Journal of Agricultural and Food Chemistry. 2022;70(4):934-43.
18- Bisht A, Tewari D, Kumar S, Chandra S. Network pharmacology, molecular docking, and molecular dynamics simulation to elucidate the mechanism of anti-aging action of Tinospora cordifolia. Molecular Diversity. 2024;28(3):1743-63.
19- Ezzat M, Abd Razik B. Molecular modelling design and opioid binding affinity evaluation of new 4-chromanone derivatives. Journal of microbiology, biotechnology and food sciences. 2021;10(4):531-5.
20- Bakchi B, Krishna AD, Sreecharan E, Ganesh VBJ, Niharika M, Maharshi S, et al. An overview on applications of SwissADME web tool in the design and development of anticancer, antitubercular and antimicrobial agents: A medicinal chemist's perspective. Journal of Molecular Structure. 2022;1259:132712.
21- Al Azzam KM, Negim E-S, Aboul-Enein HY. ADME studies of TUG-770 (a GPR-40 inhibitor agonist) for the treatment of type 2 diabetes using SwissADME predictor: In silico study. Journal of Applied Pharmaceutical Science. 2022;12(4):159-69.
22- Chen M, Yang J, Tang C, Lu X, Wei Z, Liu Y, et al. Improving ADMET prediction accuracy for candidate drugs: Factors to consider in QSPR modeling approaches. Current Topics in Medicinal Chemistry. 2024;24(3):222-42.
23- Jacobson KA, Gao ZG, Matricon P, Eddy MT, Carlsson J. Adenosine A2A receptor antagonists: from caffeine to selective non‐xanthines. British journal of pharmacology. 2022;179(14):3496-511.
24- Ibrahim NW, Mahdi M, Raauf AMR. Design, molecular docking, synthesis and evaluation of new isatin derivatives bearing pyridine moiety as potential tyrosine kinase inhibitors. Egyptian Journal of Chemistry. 2022;65(2):9-18.
25- Lohohola PO, Mbala BM, Bambi S-MN, Mawete DT, Matondo A, Mvondo JGM. In silico ADME/T properties of quinine derivatives using SwissADME and pkCSM webservers. International Journal of TROPICAL DISEASE & Health. 2021;42(11):1-12.
26- Zhang B, Chen J, Cao Y, Chai OJH, Xie J. Ligand design in ligand‐protected gold nanoclusters. Small. 2021;17(27):2004381.
27- Ali SBM, Hasanuzzaman M, Rahim N, Mamun M, Obaidellah UH. Analysis of energy consumption and potential energy savings of an institutional building in Malaysia. Alexandria Engineering Journal. 2021;60(1):805-20.
28- Riyadi P, Sari I, Kurniasih R, Agustini T, Swastawati F, Herawati V, et al., editors. SwissADME predictions of pharmacokinetics and drug-likeness properties of small molecules present in spirulina platensis. IOP conference series: earth and environmental science; 2021: IOP Publishing.
29- Khare S, Chatterjee T, Gupta S, Ashish P. Bioavailability predictions, pharmacokinetics and drug-likeness of bioactive compounds from Andrographis paniculata using Swiss ADME. MGM Journal of Medical Sciences. 2023;10(4):651-9.
30- Gheidari D, Mehrdad M, Hoseini F. Virtual screening, molecular docking, MD simulation studies, DFT calculations, ADMET, and drug likeness of Diaza-adamantane as potential MAPKERK inhibitors. Frontiers in Pharmacology. 2024;15:1360226.
31- Jihad MI, Mahdi MF. In silico Study of New Vascular Endothelial Growth Factor Receptor Inhibitors for The Treatment of Hepatocellular Carcinoma. Al Mustansiriyah Journal of Pharmaceutical Sciences. 2023;23(2):214-20.
32- Alwan SM, Ali R, ben Sulaiman İAI. In Silico Profiling of Histone Deacetylase 8 Inhibitory Activity: A Computational Analysis of Novel Dipeptide-Based Compounds Cross-Linked with Hydroxamic Acid. Al Mustansiriyah Journal of Pharmaceutical Sciences. 2024;24(2):178-89.
33- Sucharitha P, Reddy KR, Satyanarayana S, Garg T. Absorption, distribution, metabolism, excretion, and toxicity assessment of drugs using computational tools. Computational approaches for novel therapeutic and diagnostic designing to mitigate SARS-CoV-2 infection: Elsevier; 2022. p. 335-55.
34- Daina A, Michielin O, Zoete V. SwissADME: a free web tool to evaluate pharmacokinetics, drug-likeness and medicinal chemistry friendliness of small molecules. Scientific reports. 2017;7(1):42717.
35- Wabdan AK, Mahdi MF, Khan AK. Molecular docking, synthesis and ADME studies of new pyrazoline derivatives as potential anticancer agents. Egyptian Journal of Chemistry. 2021;64(8):4311-22.
36- Nirogi R, Bhyrapuneni G, Muddana NR, Manoharan A, Shinde AK, Mohammed AR, et al. Absorption, distribution, metabolism, excretion (ADME), drug-drug interaction potential and prediction of human pharmacokinetics of SUVN-G3031, a novel histamine 3 receptor (H3R) inverse agonist in clinical development for the treatment of narcolepsy. European Journal of Pharmaceutical Sciences. 2020;152:105425.
37- Ng HW, Zhang W, Shu M, Luo H, Ge W, Perkins R, et al., editors. Competitive molecular docking approach for predicting estrogen receptor subtype α agonists and antagonists. BMC bioinformatics; 2014: Springer.
38- Ballante F, Kooistra AJ, Kampen S, de Graaf C, Carlsson J. Structure-based virtual screening for ligands of G protein–coupled receptors: what can molecular docking do for you? Pharmacological Reviews. 2021;73(4):1698-736.
39- Giordano D, Biancaniello C, Argenio MA, Facchiano A. Drug design by pharmacophore and virtual screening approach. Pharmaceuticals. 2022;15(5):646.
40- Murugan NA, Podobas A, Gadioli D, Vitali E, Palermo G, Markidis S. A review on parallel virtual screening softwares for high-performance computers. Pharmaceuticals. 2022;15(1):63.
41- Ali YS, Mahdi MF, Abd Razik BM, Aburjai T. Design, Molecular Docking, Synthesis, Characterization and Preliminary Evaluation of Novel 1, 3, 4-Oxadiazole Derivatives as Cyclin-Dependent Kinase 2 Inhibitors. Al Mustansiriyah Journal of Pharmaceutical Sciences. 2025;25(1):94-109.
42- Nouioura G, Ghneim HK, Zbadi L, Maache S, Zouirech O, Danouche M, et al. Exploring the essence of celery seeds (Apium graveolens L.): Innovations in microwave-assisted hydrodistillation for essential oil extraction using in vitro, in vivo and in silico studies. Arabian Journal of Chemistry. 2024;17(5):105726.
43- Islamoğlu F. Molecular docking, bioactivity, adme, toxicity risks, and quantum mechanical parameters of some 1, 2-dihydroquinoline derivatives were calculated theoretically for investigation of its use as a pharmaceutical active ingredient in the treatment of multiple sclerosis (MS). Prospects in Pharmaceutical Sciences. 2024;22(4):168-87.
Downloads
Published
Issue
Section
License
Copyright (c) 2025 noor mousa, Abdull Jabar Attia, Karima Fadhil Ali
This work is licensed under a Creative Commons Attribution 4.0 International License.
How to Cite
